Clinical trials
Phase 1 Sleep Apnea Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Diego | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Brigham and Women's Hospital | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| George Washington University | 1 |
| Johns Hopkins University | 1 |
| Kai Medical, Inc. | 1 |
| Mackay Memorial Hospital | 1 |
| Mayo Clinic | 1 |
| Miller, Chipp St. Kevin, M.D. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Apnea Syndromes | 22 |
| Sleep Apnea, Obstructive | 9 |
| Apnea | 2 |
| Snoring | 2 |
| Alzheimer Disease | 1 |
| Aneurysm | 1 |
| Cheyne-Stokes Respiration | 1 |
| Hyperglycemia | 1 |
| Hyperlipidemias | 1 |
| Hypersensitivity | 1 |
Trials
Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.